5Stuart S.Martin,Philip Leder.Human MCF 1 0 A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2[J].Mol Cell Biol,2001,21(19):6529.
6Sawan A,Lascal 1,Verun M.NDP-k Nm23 expression in human breast cancer in relation to relapse survival and other prognostic factors;An Immunochemical Study J Pat hol,1994.172:27.
7Read JC.Bcl2 and the regulation of programmed cell death[J].J Cell Biol,1994,124:1.
8Kaklamanis L,Savage A,Whitehouse R.Bcl-2 protein expression:association with p53 and prognosis in colorectal cancer[J].Br J Cancer,1998,77(11):1864.
9Zhai Y L,Nikaido T,Toki T.Prognostic significance of Bcl 2 expression in leiomyosarcoma of the uterus[J].Br'J Cancer,1999,80(10):1658.
10Chen Y,Sato M,Fujimura S.Expression of Bcl2,bax,and p53 protein in carcinogenesis of squmous cell lung cancer[J].Anticancer Res,1999,19:1351.
二级参考文献16
1[1]Kerr JF, Wyllie AH and Gurrie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972, 26:239～257
2[5]Gavrieli Y, Sherman Y and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol, 1992, 119:493～501
3[6]Raff MC. Social controls on cell survival and cell death. Nature, 1992, 356:397～400
4[7]Yin C, Knudson CM, Korsmeyer SJ, et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature, 1997,385:637～640
5[8]Mcdonnell TJ, Beham A, Sarkiss M, et al. Importance of the Bcl-2 family in cell death regulation. Experientia, 1996, 52:1008～1017
6[9]Diller L, Kassel J, Nelson CE, et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol, 1990,
7[10]:5772～578110.Rowan S, and Fisher DE. Mechanisms of apoptotic cell death.Leukemia, 1997, 11:457～465
8[11]Miyashita T, and Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 1995,80:293～299
9[12]Mougin C, Humbey O, and Gay C, et al. Human papillomaviruses, ce 1l cycle and cervical cancer. J Gynecol Obstet Biol Reprod (Paris), 2000, 29(1): 13～20
10[13]Thomas M, Pim D, and Banks L. The role of the E6-p53 interaction in the molectular pathogenesis of HPV. Oncogene,1999, 18(53): 7690～7700
2Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [ J ]. Science, 2002, 296 ( 5567 ) : 550-553.
3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [ J ] . CA Cancer J Clin, 2010, 60 ( 5 ) : 277-300.
4Lage H. An overview of cancer muhidrug resistance : a still unsolved problem [ J ]. Cell Mol Life Sci, 2008, 65 ( 20 ) : 3145-3167.
5Cao N, Cheng D, Zou S, et al. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer ceils [J ] . Biomaterials, 2011, 32 ( 8 ) : 2222- 2232.
7Dive C. Avoidance of' apoptosis as a mechanism of drug resistance[ J ]. J Intern Med Suppl, 1997, 740 : 139-145.
8Kastl L, Brown I, Sehofield AC. miRNA-34a is associated with docetaxel resistance in human breast eaneer eells [ J ]. Breast Cancer Res Treat, 2012, 131 ( 2 ) : 445-454.
9Brummelkamp TR, Bernards R, Aqami R. A system for stable expressionof short interfering RNAs in mammalian cells [Jl. science,2002,296 (5567) :550-553.
10Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer Clin,2005,55(2) :74-108.
